It’s still experimental, but a potential new weapon to fight the most common form of adult leukemia is now undergoing clinical trials at the University of Kansas Cancer Center. As Kansas Public Radio’s Bryan Thompson reports, it’s a drug first approved more than 25 years ago to treat arthritis.